Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Diseases × palbociclib × Clear all

Phase

Status

Active not recruiting 3 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Estrogen Receptor-positive Breast Cancer 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thrombosis 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Lung Neoplasms 1 Inflammation 1 Immune System Diseases 1 HER2+ Breast Cancer 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Colonic Neoplasms 1 Chordoma 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1 Breast Diseases 1 Brain Neoplasms 1

Interventions

pyrotinib 3 Docetaxel 3 Trastuzumab 2 Letrozole 2 Epirubicin 2 Doxorubicin 2 Cyclophosphamide 2 Capecitabine 2 palbociclib 1 exemestane 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surgimend 1 Sodium Chloride 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Lapatinib 1 Goserelin 1 Drug Therapy 1 Drug Evaluation 1 Cryotherapy 1 Carboplatin 1 Botulinum Toxins, Type A 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03756090 2018-12-07

PECP

Zhejiang Cancer Hospital

Phase NA Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡